The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Whole Body Imaging

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Whole Body Imaging


Psychiatry related information on Whole Body Imaging


High impact information on Whole Body Imaging

  • In each case whole-body scanning with gallium 67 was inferior to the other methods used to detect extrathoracic tumor deposits [7].
  • The development of infection over 6 h and its regression after kanamycin treatment were visualized by whole-body imaging [8].
  • Distinctive images of this amyloid-specific deposition of labeled serum amyloid P component were derived from whole body scanning, in vivo, of amyloidotic mice [9].
  • Their principal value resides in the Tg antibody-positive patients in whom a positive or a negative mRNA value might have indicated or obviated the need for a whole-body scan [10].
  • The purpose of this study was to determine whether chronic thyroid hormone suppression therapy (THST) is prothrombotic.We obtained blood samples from 14 thyroid cancer patients while on THST and after they had become hypothyroid for radioiodine whole-body scanning and therapy [11].

Chemical compound and disease context of Whole Body Imaging


Biological context of Whole Body Imaging


Anatomical context of Whole Body Imaging


Associations of Whole Body Imaging with chemical compounds

  • At the end of follow-up in treated patients a complete remission (normalization of serum Tg off L-thyroxine and negative diagnostic (131)I whole body scan) was observed in 10 patients (33.3%) [22].
  • Stimulation with recombinant human TSH (rhTSH) has been introduced in clinical practice as an effective alternative to thyroid hormone withdrawal for the diagnostic follow-up (Tg measurement and 131-iodine whole-body scan) of patients with differentiated thyroid cancer [23].
  • At the time of the study, all patients were free of cancer (negative 131 Iodine whole body scan and serum thyroglobulin levels less than 0.3 micrograms/L) and all were receiving doses of T4 sufficiently high to prevent a rise in a serum thyroid-stimulating hormone concentration after an iv bolus of TRH [24].
  • PURPOSE: To determine if stunning can be seen with a 185-MBq (5-mCi) dose of iodine 131 (131I) at diagnostic whole-body scanning and, if stunning is seen, determine if there is any 131I therapeutic efficacy [25].
  • Whole-body imaging of thallium-201 after six different stress regimens [26].

Gene context of Whole Body Imaging


Analytical, diagnostic and therapeutic context of Whole Body Imaging


  1. Prospective study of fluorodeoxyglucose-positron emission tomography imaging of lymph node basins in melanoma patients undergoing sentinel node biopsy. Wagner, J.D., Schauwecker, D., Davidson, D., Coleman, J.J., Saxman, S., Hutchins, G., Love, C., Hayes, J.T. J. Clin. Oncol. (1999) [Pubmed]
  2. A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. Mazzaferri, E.L., Robbins, R.J., Spencer, C.A., Braverman, L.E., Pacini, F., Wartofsky, L., Haugen, B.R., Sherman, S.I., Cooper, D.S., Braunstein, G.D., Lee, S., Davies, T.F., Arafah, B.M., Ladenson, P.W., Pinchera, A. J. Clin. Endocrinol. Metab. (2003) [Pubmed]
  3. Low specificity of blood thyroglobulin messenger ribonucleic acid assay prevents its use in the follow-up of differentiated thyroid cancer patients. Elisei, R., Vivaldi, A., Agate, L., Molinaro, E., Nencetti, C., Grasso, L., Pinchera, A., Pacini, F. J. Clin. Endocrinol. Metab. (2004) [Pubmed]
  4. Differential shunting in the diagnosis of patent ductus arteriosus with Eisenmenger physiology by radionuclide angiography. Thomas, J.L., Scherer, J., Kahl, F.R., Watson, N., Cowan, R. Radiology. (1978) [Pubmed]
  5. Effects of therapeutic doses of 131I in thyroid papillary carcinoma patients with elevated thyroglobulin level and negative 131I whole-body scan: comparative study. Koh, J.M., Kim, E.S., Ryu, J.S., Hong, S.J., Kim, W.B., Shong, Y.K. Clin. Endocrinol. (Oxf) (2003) [Pubmed]
  6. The role of fluorine-18-deoxyglucose (FDG) positron emission tomography (PET) whole body scan (WBS) in the staging and follow-up of cancer patients: our first experience. Ferlin, G., Rubello, D., Chierichetti, F., Zanco, P., Bergamin, R., Trento, P., Fini, A., Cargnel, S. Tumori. (1997) [Pubmed]
  7. Gallium scans for staging small cell lung cancer. Brereton, H.D., Line, B.R., Londer, H.N., O'Donnell, J.F., Kent, C.H., Johnson, R.E. JAMA (1978) [Pubmed]
  8. Spatial-temporal imaging of bacterial infection and antibiotic response in intact animals. Zhao, M., Yang, M., Baranov, E., Wang, X., Penman, S., Moossa, A.R., Hoffman, R.M. Proc. Natl. Acad. Sci. U.S.A. (2001) [Pubmed]
  9. Imaging of experimental amyloidosis with 131I-labeled serum amyloid P component. Caspi, D., Zalzman, S., Baratz, M., Teitelbaum, Z., Yaron, M., Pras, M., Baltz, M.L., Pepys, M.B. Arthritis Rheum. (1987) [Pubmed]
  10. Detection of thyrotropin-receptor messenger ribonucleic acid (mRNA) and thyroglobulin mRNA transcripts in peripheral blood of patients with thyroid disease: sensitive and specific markers for thyroid cancer. Chinnappa, P., Taguba, L., Arciaga, R., Faiman, C., Siperstein, A., Mehta, A.E., Reddy, S.K., Nasr, C., Gupta, M.K. J. Clin. Endocrinol. Metab. (2004) [Pubmed]
  11. Is thyroid hormone suppression therapy prothrombotic? Horne, M.K., Singh, K.K., Rosenfeld, K.G., Wesley, R., Skarulis, M.C., Merryman, P.K., Cullinane, A., Costello, R., Patterson, A., Eggerman, T., Bernstein, D.M., Pucino, F., Csako, G. J. Clin. Endocrinol. Metab. (2004) [Pubmed]
  12. Gastric volvulus detected with iodine-131 whole-body imaging. Zucker, R.J., Bradley, Y.C., Toney, M.O., Bridwell, R.S. Clinical nuclear medicine. (2000) [Pubmed]
  13. Tc-99m dicarboxypropane diphosphonate uptake in ovarian fibrothecoma. Danieli, R., Moncliovic, N., Pesce, G., Reiner, M., Bernier, J. Clinical nuclear medicine. (2000) [Pubmed]
  14. Evaluation of pentavalent Tc-99m DMSA scintigraphy in small cell and nonsmall cell lung cancers. Atasever, T., Gündoğdu, C., Vural, G., Kapucu, L.O., Karalezli, A., Unlü, M. Nuklearmedizin. (1997) [Pubmed]
  15. Meningioma detected incidentally on early Tc-99m MDP whole-body imaging during a workup for breast cancer. Cheng, T.F., Chen, Y.K., Kao, C.H. Clinical nuclear medicine. (2005) [Pubmed]
  16. Non-invasive determination of the distribution of cardiac output in man at rest and during exercise. Svensson, S.E., Lomsky, M., Olsson, L., Persson, S., Strauss, H.W., Westling, H. Clinical physiology (Oxford, England) (1982) [Pubmed]
  17. Usefulness of fine needle aspiration cytology in the diagnosis of loco-regional recurrence of differentiated thyroid carcinoma. Bernier, M.O., Moisan, C., Mansour, G., Aurengo, A., Ménégaux, F., Leenhardt, L. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. (2005) [Pubmed]
  18. In vivo patterns of heme oxygenase-1 transcription. Contag, C.H., Stevenson, D.K. Journal of perinatology : official journal of the California Perinatal Association. (2001) [Pubmed]
  19. Short-term effectiveness of low-dose radioiodune ablative treatment of thyroid remnants after thyroidectomy for differentiated thyroid cancer. Vermiglio, F., Violi, M.A., Finocchiaro, M.D., Baldari, S., Castagna, M.G., Moleti, M., Mattina, F., Pio Lo Presti, V., Bonanno, N., Trimarchi, F. Thyroid (1999) [Pubmed]
  20. Functional imaging of multidrug resistant phenotype by 99mTc-MIBI scan in patients with multiple myeloma. Fonti, R., Del Vecchio, S., Zannetti, A., De Renzo, A., Catalano, L., Pace, L., Rotoli, B., Salvatore, M. Cancer Biother. Radiopharm. (2004) [Pubmed]
  21. Hydatid disease: the value of whole-body screening by scintigraphy with technetium-99m-labelled red blood cells. Front, D., Israel, O. The British journal of radiology. (1981) [Pubmed]
  22. Outcome of differentiated thyroid cancer with detectable serum Tg and negative diagnostic (131)I whole body scan: comparison of patients treated with high (131)I activities versus untreated patients. Pacini, F., Agate, L., Elisei, R., Capezzone, M., Ceccarelli, C., Lippi, F., Molinaro, E., Pinchera, A. J. Clin. Endocrinol. Metab. (2001) [Pubmed]
  23. Prediction of disease status by recombinant human TSH-stimulated serum Tg in the postsurgical follow-up of differentiated thyroid carcinoma. Pacini, F., Molinaro, E., Lippi, F., Castagna, M.G., Agate, L., Ceccarelli, C., Taddei, D., Elisei, R., Capezzone, M., Pinchera, A. J. Clin. Endocrinol. Metab. (2001) [Pubmed]
  24. A therapeutic dilemma: suppressive doses of thyroxine significantly reduce bone mineral measurements in both premenopausal and postmenopausal women with thyroid carcinoma. Diamond, T., Nery, L., Hales, I. J. Clin. Endocrinol. Metab. (1991) [Pubmed]
  25. 131I therapeutic efficacy is not influenced by stunning after diagnostic whole-body scanning. Dam, H.Q., Kim, S.M., Lin, H.C., Intenzo, C.M. Radiology. (2004) [Pubmed]
  26. Whole-body imaging of thallium-201 after six different stress regimens. Pennell, D.J., Ell, P.J. J. Nucl. Med. (1994) [Pubmed]
  27. Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Chiovato, L., Latrofa, F., Braverman, L.E., Pacini, F., Capezzone, M., Masserini, L., Grasso, L., Pinchera, A. Ann. Intern. Med. (2003) [Pubmed]
  28. Diagnostic 131-iodine whole-body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment. Pacini, F., Capezzone, M., Elisei, R., Ceccarelli, C., Taddei, D., Pinchera, A. J. Clin. Endocrinol. Metab. (2002) [Pubmed]
  29. Follow-up of low risk patients with papillary thyroid cancer: role of neck ultrasonography in detecting lymph node metastases. Torlontano, M., Attard, M., Crocetti, U., Tumino, S., Bruno, R., Costante, G., D'Azzò, G., Meringolo, D., Ferretti, E., Sacco, R., Arturi, F., Filetti, S. J. Clin. Endocrinol. Metab. (2004) [Pubmed]
  30. Immunohistochemical analysis of sodium iodide symporter expression in metastatic differentiated thyroid cancer: correlation with radioiodine uptake. Castro, M.R., Bergert, E.R., Goellner, J.R., Hay, I.D., Morris, J.C. J. Clin. Endocrinol. Metab. (2001) [Pubmed]
  31. Usefulness of technetium-99m hydroxymethylene diphosphonate scans in localizing bone metastases of differentiated thyroid carcinoma. Tenenbaum, F., Schlumberger, M., Bonnin, F., Lumbroso, J., Aubert, B., Benali, H., Parmentier, C. European journal of nuclear medicine. (1993) [Pubmed]
  32. Somatostatin receptor scintigraphy with 111In-pentetreotide in non-functioning gastroenteropancreatic neuroendocrine tumors. Schillaci, O., Spanu, A., Scopinaro, F., Falchi, A., Corleto, V., Danieli, R., Marongiu, P., Pisu, N., Madeddu, G., Delle Fave, G., Madeddu, G. Int. J. Oncol. (2003) [Pubmed]
  33. Thallium-201 imaging in evaluation of Hodgkin's disease. Dadparvar, S., Hussain, R., Esteves, F., Yu, J.Q., Grewal, R.K., Arif, S., Cruz, R., Barbaria, C.J., Woods, K., Styler, M.J. Cancer journal (Sudbury, Mass.) (2002) [Pubmed]
  34. Recombinant thyrotropin versus thyroid hormone withdrawal in evaluating patients with thyroid carcinoma. Ladenson, P.W. Seminars in nuclear medicine. (2000) [Pubmed]
  35. Use of fractionated doses of iodine-131 for ablation of thyroid remnants. Wang, S.J., Liu, T.J. Zhonghua Yi Xue Za Zhi (Taipei) (2002) [Pubmed]
WikiGenes - Universities